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Abstract
Background: Maternal predictors of folic acid (FA) supplementation use to reduce offspring risk of neural
tube defects are well known, while paternal determinants for maternal FA use are less known. Such knowledge is
important to increase women’s compliance to recommended periconceptional FA use.
Methods: In a nation-wide study of 683,785 births registered in the Medical Birth Registry of Norway during
1999–2010, the associations between paternal characteristics (age, education, occupation, country of origin)
and maternal FA use were estimated by relative risks (RR) with 95% confidence intervals (CI), using log-
binomial regression.
Results: Maternal FA use before and during pregnancy (adequate FA use) was found in 16% of the births.
The association between paternal age and adequate FA use was inversely U-shaped; adjusted RRs for adequate FA use
were 0.35 (95% CI 0.28–0.43) and 0.72 (95% CI 0.71–0.74) for paternal age < 20 and≥ 40 years, respectively, comparing
age 30–34 years. Compulsory education (1–9 years) among fathers was compared to tertiary education; the RR was 0.69
(95% CI 0.68–0.71) for adequate FA use. The lower risk of adequate FA use for paternal compulsory education was present
in all categories of maternal education. Occupation classes other than “Higher professionals” were associated
with decreased risk of adequate FA use, compared with the reference “Lower professionals”. RR for adequate
FA use was 0.58 (95% CI 0.56–0.60) comparing fathers from “Low/middle-income countries” with fathers born
in Norway.
Conclusion: Adequate FA use in the periconceptional period was lower when fathers were younger or older
than 30–34 years, had shorter education, had manual or self-employed occupations, or originated from low/
middle-income countries. Partners may contribute to increase women’s use of periconceptional FA
supplementation.
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Background
Folate is necessary in foetal development, and folic acid
(FA) supplementation is widely acknowledged to reduce
the risk of neural tube defects (NTDs) [1–5]. FA is the
synthetic form of the B-vitamin folate, which is essential
in the synthesis of DNA, methylation, and DNA repair
[6]. Start of FA supplementation prior to conceiving is
important in order to reduce the risk of NTDs because
the neural tube closes between 21 and 28 days after
conception [7].
Randomized clinical trials and non-randomized
intervention trials have demonstrated that periconcep-
tional FA use reduces the risk of NTDs [1–3]. Recent
studies have reported that FA is associated with protec-
tion against other neurodevelopmental disorders and
some severe pregnancy complications [8–10]. The pro-
tective effect of FA on NTDs has led health authorities
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in several countries, including Norway, to recommend
women to take FA supplements before pregnancy and in
early pregnancy [11–13].
Many countries in Europe, including Norway, have
performed information campaigns to increase the use of
periconceptional FA supplementation among women
planning pregnancy [14–16]. Presently there is no
mandatory folic acid food fortification in Norway [17].
Official Norwegian guidelines from 1998, states that all
women planning their pregnancy should use 0.4 mg FA
daily from 1 month before pregnancy and throughout
the first 2–3 months of pregnancy to reduce the risk of
NTDs [12]. However, the proportion of preconception
FA supplementation use in Norway is still too low [18]
and by 2015 it was 33% [19].
Previous studies have identified maternal factors
associated with inadequate FA in the periconceptional
period, such as low maternal age, shorter education,
single parenthood, unplanned pregnancy, lower parity,
smoking, alcohol use, less physical activity, or originating
from a foreign country [15, 16, 20–24].
Since couples tend to exhibit concordant health
behaviour’s for dietary intake, smoking, alcohol
consumption, physical activity, and body mass index
(BMI) [25–27], a woman’s partner may contribute to her
use of periconceptional FA supplements. In fact, in an
early report from the Norwegian Mother and Child
Cohort Study (MoBa), 2000–2003, counting 22,500
women, FA supplements were used more frequently
among women with partners with a higher education
[22]. However, the study did not assess other paternal
factors or combined paternal and maternal factors as to
identify women with inadequate FA use.
Taking advantage of the Medical Birth Registry of
Norway that to our knowledge is the only national regis-
try with information on periconceptional use of FA sup-
plements [28], we updated parent information with data
from national registries to investigate whether paternal
factors (age, education, occupation, country of origin)




Maternal FA use before and/or during pregnancy was
collected from the Medical Birth Registry of Norway
(MBRN) [28]. Paternal and maternal demographic data
came from the National Registry (NR). Information on
paternal and maternal occupation originated from the
Norwegian Labour and Welfare Administration (NAV),
and we retrieved paternal and maternal educational data
from the Norwegian National Education Database
(NUDB) [29].
MBRN is a population-based registry containing
information on all births in Norway since 1967 [28]. The
registry holds demographic information on the mother
and the father, the mother’s health before and during
pregnancy, including chronic diseases, information on in
vitro fertilization (IVF), complications during pregnancy
and delivery as well as information on the infant, includ-
ing birth defects and other perinatal problems. Midwives
and physicians attending the deliveries register the data.
Since 1967, there has been mandatory reporting of all
live and stillbirths from the 16 gestational week to
MBRN.
NR contains demographic information on all residents
in Norway since 1960, including the date of birth,
country of origin, and the dates of immigration, emigra-
tion, or death [30]. NR assigns a unique personal identi-
fication number to all individuals born or immigrated to
Norway, enabling accurate record linkages.
NAV was established in 2006 after governmental
reorganization of the Directorate of Labour in Norway
(founded in 1945), and has registered information on
occupation, health status, and social benefits of all indi-
viduals with residence in Norway since 1992. The
Norwegian occupational code system is based on the
International Standard Classification of Occupations
(ISCO), revised version from 1988 [31].
Since 1970, NUDB holds information on all individ-
uals’ education history from primary school up to
doctoral studies in one database [32]. The classification
is based on the Norwegian Standard Classification of
Education.
Maternal FA supplement use
We constructed a binary variable for intake of FA sup-
plement use (0.4 mg/day) (regardless of concomitant
multivitamin use) registered in the MBRN since Decem-
ber 1998 onwards; adequate FA use (recommended FA
supplementation before and during pregnancy), and in-
adequate FA use (FA supplementation only before preg-
nancy, or only during pregnancy, or no record of FA
use).
MBRN also registers multivitamin use, but our investi-
gation focused on periconceptional FA use as such in-
take was according to official guidelines.
Paternal characteristics
We used the following paternal variables in our
analyses of adequate FA supplementation; paternal
age (< 20, 20–24, 25–29, 30–34, 35–39, 40+ years);
education (Compulsory (1–9 years), Intermediate (10–
12 years), Tertiary (13–19 years)); occupation accord-
ing to the class scheme of Erikson, Goldthorpe, and
Portocarero (I Higher professionals, II Lower profes-
sionals, IIIa Higher routine, IIIb Lower routine, IV
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Other self-employed workers, V Technicians, VI
Skilled, VII Semiskilled and unskilled, VIIb Agricul-
tural, Unclassified) (EGP) [33]; and country of origin
according to the classification by World Health
Organization, Health statistics and information sys-
tems, Estimates for 2000–2012 (Norway, High income
countries, Low/middle-income countries) [34].
Covariates
We used directed acyclic graphs (DAGs) and
subject-matter knowledge to select a minimally sufficient
adjustment set of variables that identify the uncon-
founded association of paternal characteristics on ad-
equate maternal FA supplementation use [35–37].
The potential confounders of the paternal characteris-
tics and maternal FA use relationship included year of
childbirth (continuous), paternal age (< 20, 20–24, 25–
29, 30–34, 35–39, 40+ years), education (Compulsory,
Intermediate, Tertiary), or country of origin (Norway,
High-income countries, Low/middle-income countries).
Furthermore, we included maternal age (< 20, 20–24,
25–29, 30–34, 35–39, 40+ years), maternal education
(Compulsory, Intermediate, Tertiary), and maternal
country of origin (Norway, High-income countries, Low/
middle-income countries) as possible confounders of the
associations between paternal age, education, or country
of origin, and maternal adequate FA use.
Maternal smoking was not included in the final
models because smoking was not considered a con-
founder of the association of paternal characteristics on
maternal FA supplementation use [38].
Study population
During 1999–2010, 716,021 births were registered in
MBRN. We excluded births (induced abortions) without
information on FA or multivitamin supplementation use
(2519) and births without maternal identification num-
ber (4091). For multiple births, we included data for the
first birth and excluded 12,927 next born individuals.
Among the remaining 696,484 births, we excluded
12,699 births without paternal identification number,
leaving 683,785 live births and stillbirths for analyses.
Statistical analysis
Associations between paternal characteristics (age, edu-
cation, occupation, country of origin) and maternal FA
use were estimated as relative risks (RRs) with 95% con-
fidence intervals (CIs) by log-binomial regression, using
the log-link function in Stata version 15 [39]. The 95%
CIs were based on robust variance estimation with the
sandwich estimator to correct for the intra-individual
correlation in women with more than one pregnancy
during the study period [40]. Births with missing data on
covariates were excluded from the analyses. P-values for
overall difference between the categories of paternal
characteristics were calculated using likelihood ratio
tests. We evaluated and tested the potential effect modi-
fication of the association between paternal education
and maternal FA use by stratification and likelihood ra-
tio test.
Results
Our study included 683,785 births during 1999–2010.
Table 1 presents the characteristics of the parents. The
median ages of the fathers and mothers at childbirth
were 33 and 30 years, respectively. For about 41% of the
births, the mothers were primiparous, and about 2% of
the births were conceived after in vitro fertilization
(IVF). The majority of the births were of
Norwegian-born parents (84% of the fathers and 83% of
the mothers). For about 34% of the births, the fathers
had tertiary education, and for about 19% of the births,
the fathers had compulsory education only. The paternal
educational level varied by his country of origin. Fathers
originating from low/middle-income countries generally
had lower educational level compared to fathers origin-
ating from Norway and other high-income countries
(not shown). Occupation classified as “Lower profes-
sionals,” accounted for 22% of all the births. For about
14% of the births, the women smoked daily at the start
of pregnancy, about 3% smoked intermittently, and 67%
did not smoke. Nearly 17% of the smoking data were
missing.
For about 16% of all births in the study population,
the mothers were assigned to the category adequate FA
supplementation users. However, during 1999 through
2010, the proportion of adequate FA supplementation
use increased from 4% at the start of the study period
(1999) to 26% in 2010.
Table 2 presents crude and adjusted RRs for ad-
equate maternal periconceptional FA use by paternal
variables (determinants). Adjusted analyses showed an
inverse “U-shaped” relationship between paternal age
and adequate maternal FA supplement use where the
smallest RRs were found for paternal age below
20 years (RR 0.35 (95% CI 0.28–0.43)), 20–24 years
(RR 0.68 (95% CI 0.66–0.71)), and 40 years and above
(RR 0.72 (95% CI 0.71–0.74)) compared to paternal
age 30–34 years. Paternal compulsory education was
associated with reduced risk of adequate FA use (RR
0.69 (95% CI 0.68–0.71)) compared to paternal ter-
tiary education. All paternal occupation classes were
associated with reduced risk of adequate FA use ex-
cept for “I Higher professionals”, when compared to
“II Lower professionals”, in particular “VII Semiskilled
and unskilled” (RR 0.75 (95% CI 0.73–0.76)), and
“VIIb Agricultural” (RR 0.73 (95% CI 0.69–0.78)).
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Mothers whose children’s father originated from low/
middle-income countries had also a reduced risk of ad-
equate FA use (RR 0.58 (95% CI 0.56–0.60)) compared
to fathers originating from Norway.
Table 3 presents crude and adjusted RRs with 95% CIs
of adequate FA use by maternal and paternal education.
Adjusted analyses showed that adequate FA use was less
likely in births were fathers had compulsory education,
regardless of maternal education. The association of pa-
ternal compulsory education and recommended FA use
was weakened by increasing level of maternal education.
However, even when the mother had tertiary education,
the association of compulsory paternal education on ad-
equate maternal FA use was significant (RR 0.75 (95% CI
0.73–0.77)), compared to fathers with tertiary education.
Discussion
The present population-based study (683,785 births
during 1999–2010) showed that recommended maternal
FA use was low among fathers who were young or older
at their children’s birth, had achieved shorter education,
held a manually or self-employed occupation, or
originated from low/middle-income countries. Even
among mothers who had achieved higher education, rec-
ommended periconceptional maternal FA use was low
among less educated fathers.
Several studies have investigated the association be-
tween maternal socio-demographic, reproductive, and
medical characteristics and adherence to recommended
intake of periconceptional FA. A common feature among
mothers is that young age, low educational level, low
Table 1 Paternal and maternal characteristics in 683,785 births
in Norway, 1999–2010
Births
Fathers % Mothers %
Number of births 683,785 100.0 683,785 100.0
Age
< 20 4401 0.6 15,464 2.3
20–24 48,448 7.1 100,016 14.6
25–29 162,671 23.8 223,480 32.7
30–34 235,401 34.4 228,203 33.4
35–39 151,540 22.2 99,727 14.6
40+ 81,324 11.9 16,895 2.5
Education
Compulsory education (1–9 years) 130,953 19.2 125,479 18.4
Intermediate (10–12 years) 302,384 44.2 230,320 33.7
Tertiary education (13–19 years) 229,818 33.6 298,036 43.6
Missing data 20,630 3.0 29,950 4.4
Occupational class a
I Higher professionals 86,635 12.7 50,650 7.4
II Lower professionals 152,781 22.3 122,804 18.0
IIIa Higher routine 77,540 11.3 197,174 28.8
IIIb Lower routine 40,070 5.9 114,795 16.8
IV Other self-employed workers 358 0.1 119 0.0
V Technicians 5550 0.8 1492 0.2
VI Skilled 108,755 15.9 15,961 2.3
VII Semiskilled and unskilled 111,584 16.3 73,994 10.8
VIIb Agricultural 7663 1.1 2720 0.4
Unclassified 52,824 7.7 51,264 7.5
Missing data 40,025 5.9 52,812 7.7
Country of origin b
Norway 574,602 84.0 567,241 83.0
High income countries 33,487 4.9 30,920 4.5
Low/middle-income countries 75,497 11.0 85,597 12.5





Missing data 9028 1.3







Table 1 Paternal and maternal characteristics in 683,785 births
in Norway, 1999–2010 (Continued)
Maternal chronic disease c
No 623,817 91.2
Yes 59,968 8.8




Missing data 114,808 16.8
Maternal folic acid use in pregnancy
No use 371,820 54.4
Only before 8930 1.3
Only during 192,169 28.1
Before and during 110,866 16.2
aCategorized according to the class scheme of Erikson, Goldthorpe and
Portocarero (EGP) [33]
bCategorized according to the classification by World Health Organization,
Health statistics and information systems, Estimates for 2000–2012 [34]
cAsthma, hypertension, kidney disease, chronic urinary infection, rheumatoid
arthritis, heart disease, epilepsy, diabetes mellitus (type I or II), and
thyroid disease
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socioeconomic status, unplanned pregnancy, higher par-
ity, smoking, single marital status, and non-western
birthplace is the most important determinants for inad-
equate FA supplementation use [20–23]. Furthermore,
maternal chronic diseases and IVF were positively asso-
ciated with adequate periconceptional FA supplementa-
tion use [22, 38].
In Denmark, a cross-sectional study consisting of
22,000 pregnant women (primiparious and multipar-
ous) showed that only 14% of the women used FA as
recommended and compliance was positively associ-
ated with being primiparous, older than 25 years and
non-smoker [21]. Similarly, for about 16% of the
births in our study, the mothers had followed the
Table 2 Relative risks (RRs) with 95% confidence intervals (95% CIs) of adequate maternal periconceptional folic acid supplement
use (before and during pregnancy) by paternal characteristics, in 683,785 births, Norway, 1999–2010
Folic acid supplementation
use
Unadjusted Adjusted for paternal factors a b Further adjusted for maternal
factors a c
Characteristics Yes No RR* 95% CI RR* 95% CI RR* 95% CI
Paternal age (years)
< 20 86 4315 0.11 0.09–0.13 0.10 0.08–0.13 0.35 0.28–0.43
20–24 3325 45,123 0.37 0.36–0.39 0.37 0.36–0.38 0.68 0.66–0.71
25–29 22,886 139,785 0.76 0.75–0.78 0.77 0.76–0.79 0.94 0.93–0.96
30–34 43,348 192,053 1.00 Reference 1.00 Reference 1.00 Reference
35–39 28,488 123,052 1.02 1.01–1.03 0.97 0.96–0.99 0.90 0.89–0.91
40+ 12,733 68,591 0.85 0.83–0.87 0.80 0.78–0.81 0.72 0.71–0.74
Paternal education
Compulsory (1–10 years) 11,694 119,259 0.40 0.39–0.40 0.52 0.51–0.53 0.69 0.68–0.71
Intermediate (11–13 years) 45,411 256,973 0.67 0.66–0.67 0.75 0.74–0.76 0.87 0.85–0.88
Tertiary (14–20 years) 51,894 177,924 1.00 Reference 1.00 Reference 1.00 Reference
Missing data 1867 18,763
Paternal occupational class d
I Higher professionals 19,957 66,678 1.05 1.04–1.07 1.05 1.03–1.06
II Lower professionals 33,366 119,415 1.00 Reference 1.00 Reference
IIIa Higher routine 12,292 65,248 0.73 0.71–0.74 0.89 0.88–0.91
IIIb Lower routine 5352 34,718 0.61 0.59–0.63 0.85 0.83–0.87
IV Other self-employed workers 60 298 0.77 0.61–0.97 0.83 0.65–1.05
V Technicians 836 4714 0.69 0.65–0.74 0.89 0.84–0.95
VI Skilled 15,174 93,581 0.64 0.63–0.65 0.84 0.83–0.86
VII Semiskilled and unskilled 11,643 99,941 0.48 0.47–0.49 0.75 0.73–0.76
VIIb Agricultural 908 6755 0.54 0.51–0.58 0.73 0.69–0.78
Unclassified 7575 45,249 0.66 0.64–0.67 0.96 0.94–0.99
Missing data 3703 36,322
Paternal country of origin e
Norway 99,339 475,263 1.00 Reference 1.00 Reference 1.00 Reference
High income countries 6535 26,952 1.13 1.10–1.16 1.06 1.04–1.09 1.06 1.03–1.08
Low-middle-income countries 4975 70,522 0.38 0.37–0.39 0.35 0.34–0.36 0.58 0.56–0.60
Missing data 17 182
aAll RRs for adequate folic acid supplementation adjusted for year of childbirth (continuous)
bRRs by paternal age, no other adjustment for paternal factors; RRs by paternal education adjusted for paternal age (< 20, 20–24, 25–29, 30–34, 35–39, 40+),
paternal country of origin (Norway, high-income countries, low/middle-income countries); RRs by paternal occupation adjusted for paternal age, fathers country of
origin, fathers education (compulsory, intermediate, tertiary); and RR by paternal origin of country, no other adjustment for paternal factors
cRRs by paternal age, further adjusted for maternal age (< 20, 20–24, 25–29, 30–34, 35–39, 40+); RRs by paternal education, further adjusted for maternal
education (compulsory, intermediate, tertiary); RRs by paternal occupation, no further adjustment for maternal factors; RRs by paternal country of origin adjusted
for maternal country of origin (Norway, High-income countries, Low/middle-income countries)
dCategorized according to the class scheme of Erikson, Goldthorpe and Portocarero (EGP) [33]
eCategorized according to the classification by World Health Organization, Health statistics and information systems, Estimates for 2000–2012 [34]
*p-value for difference between categories of paternal characteristics was < 0.001 using likelihood ratio test
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national guidelines of FA use in the study period
(1999–2010).
In Norway, a publication from the Norwegian Mother
and Child Cohort Study (MoBa), comprising 27% of the
births registered in MBRN during 2000–2003, showed
similar results to ours [22]. They found a positive associ-
ation between paternal education and recommended
periconceptional FA use. In pregnancies with fathers
having university or college education the adjusted rela-
tive risk (RR) of periconceptional maternal FA use was
1.4 (95% CI 1.1–1.8) compared to pregnancies with fa-
thers with primary education. However, the association
was weaker than for maternal education. When paternal
tertiary education was compared to paternal compulsory
education (reference) in our analyses, we found a similar
result for adjusted RR of 1.45 (95% CI 1.42–1.48).
Couples who live together share the same environ-
ment, social network, financial resources, and to some
extent, the same health risk; beneficial or negative to
health outcomes depending on the health behaviour of
the spouses [25, 27]. Furthermore, a Dutch study of
40,000 individuals aged 25–74 years showed that women
seems more affected by their partner’s educational level
than men are with regard to healthy behaviour [41].
In accordance with our findings, a cross-sectional
household survey conducted in Pakistan (comprising
6266 women), showed that maternal intake of iron and
FA supplements was positively associated with the edu-
cational status of the mothers’ husband [42].
The association of ethnic background and maternal
periconceptional FA use have been studied in Norway
and other European countries (Netherlands, Belgium,
Ireland and the United Kingdom) [23, 43–46]. These
studies show that supplement use is less common
among most ethnic minority groups than among the
comparison groups. We have similar findings in our
study, showing a lower risk of adequate maternal FA use
among fathers originating from low/middle-income
countries.
The strengths of our study included use of compre-
hensive data from population-based registries in Norway
that assures generalizability of our results, and registra-
tion of individual-level information on periconceptional
FA intake for all births in Norway since 1999 (except for
terminated pregnancies).
Our study had some limitations. Maternal FA intake
could have been misclassified; in the beginning of the
study period, FA users were underreported to the MBRN
[47]. Our results may therefore be somewhat weaker
than the true associations. Furthermore, we could not
adjust for pregnancy planning, maternal physical activity
or maternal use of alcohol [16, 18, 20–24], as these po-
tential confounders/covariates were not available in our
dataset. However, a recent longitudinal study during
2014 on men’s pregnancy planning comprising about
800 participants in Sweden, showed that 81% of the
pregnancies were planned and the level of paternal edu-
cation was positively associated with pregnancy planning
[48]. Moreover, data from 22,500 mothers in the MoBa
study with deliveries recorded in 2000–2003 showed that
78% of the mothers had planned their pregnancy [22].
However, MoBA is not entirely representative of the
Table 3 Relative risks (RRs) with 95% confidence intervals (95% CI) of adequate maternal periconceptional folic acid supplement use
(before and during pregnancy) by combining maternal and paternal education in 683,785 pregnancies, Norway, 1999–2010
Adequate folic acid use Unadjusted Adjusted a
Maternal education Paternal education Yes No RR* 95% CI RR* 95% CI
Compulsory education Compulsory education 2557 48,326 0.46 0.43–0.50 0.53 0.50–0.57
Intermediate education 4758 52,693 0.77 0.72–0.81 0.76 0.72–0.81
Tertiary education 1292 10,651 1.00 Reference 1.00 Reference
Missing information 208 4994
Intermediate education Compulsory education 5079 43,708 0.60 0.57–0.62 0.66 0.64–0.68
Intermediate education 18,055 116,378 0.77 0.75–0.79 0.81 0.79–0.83
Tertiary education 7477 35,269 1.00 Reference 1.00 Reference
Missing information 426 3928
Tertiary education Compulsory education 3805 17,985 0.70 0.67–0.72 0.75 0.73–0.77
Intermediate education 22,150 80,373 0.86 0.85–0.87 0.88 0.87–0.89
Tertiary education 42,541 126,896 1.00 Reference 1.00 Reference
Missing information 747 3539
Missing data (maternal education) 28,179 1771
aAdjusted for paternal age (< 20, 20–24, 25–29, 30–34, 35–39, 40+), year of childbirth (1999–2010 (continuous)), paternal country of origin (Norway, high income
countries, low/middle income countries), stratified by maternal education
*p values for interaction between maternal and paternal education were calculated by likelihood-ratio tests (unadjusted p value < 0.001; adjusted p value < 0.001)
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total pregnant population in Norway, since the partici-
pants are somewhat better educated, slightly older at de-
livery, and with a lower percentage of smokers than the
overall pregnant population.
Information about fathers was not available in 12,699
births (2% of all births in the study population) and were
excluded from the study population. They represent
births with fathers unreported by the pregnant woman
or fathers without identification number from the NR.
Among the excluded births (missing father information),
10% of the mothers had adequate periconceptional FA
supplementation (16% in the study population) with an
RR of 0.63 (95% CI 0.60–0.66) for adequate maternal FA
use comparing births with unregisterd fathers with
births having registered fathers.
Adjusting for maternal confounders (maternal age,
education, or country of origin) in our analysis reduced
the strength of the associations between paternal deter-
minants (age, education or country of origin) and ad-
equate maternal periconceptional FA use. This suggest
that paternal factors are important, but targeting mater-
nal demographic and socioeconomic conditions and
other factors related to low use is still important. How-
ever, our findings have implications for public health
practice. Recent research on men’s birth intentions has
shown that 63% of pregnancies were intended (wanted)
by the father [49]. Further, our study demonstrates the
importance of the partner’s impact on maternal repro-
ductive health and family planning through shared
decision-making.
Conclusions
In conclusion, our study supports the importance of fa-
ther’s prenatal role in their children’s health. In order to
improve maternal periconceptional FA supplementation
use, information and knowledge about the importance of
FA’s preventive potential needs to be directed to both
men and women. Furthermore, our findings show that
women having partners originating from low/middle-in-
come countries, partners at age < 30 and > 34 years, hav-
ing compulsory education only, and having occupations
other than “higher professional”, compared to “lower
professionals”, are particularly susceptible to low peri-
conceptional FA use. Therefore, campaigns for improved
FA supplementation use should focus particularly on
these groups.
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